BUSINESS

Ten companies disclose funding, earnings, compliance, and buybacks

PUBLISHED Feb 23, 2026, 8:54 AM ET

Read, Watch or Listen

Ten companies disclose funding, earnings, compliance, and buybacks

Media Bias Meter

Sources: 17

Center 100%

Sources: 17

United States — Ten companies issued disclosures this week reporting financing, regulatory compliance updates, operational results, and board actions. NAPCO confirmed investor meetings at Raymond James; La Rosa’s CEO and COO voluntarily cut base salaries by 60%; FibroBiologics received a Nasdaq extension to regain listing; UFP Industries and Heritage previewed fourth-quarter results and earnings dates; ROC and Abundia closed offerings raising $24 million and $20 million respectively; Martin Marietta completed an asset exchange with Quikrete; Silo Pharma authorized a $1 million share buyback; OPAL scheduled Q4 results and a March conference call. Based on 10 articles reviewed and supporting research.

By Michael Grant | JQJO News

Timeline of Events

Feb 23, 2026 — NAPCO announced management participation at Raymond James investor conference.
Feb 23, 2026 — La Rosa announced voluntary 60% base salary reductions for CEO and COO.
Feb 23, 2026 — FibroBiologics received Nasdaq extension with Feb 27 and Apr 13 compliance deadlines.
Feb 23, 2026 — ROC closed IPO for gross proceeds of $24 million; Abundia closed $20 million direct offering.
Feb 23, 2026 — Martin Marietta completed asset exchange with Quikrete; Silo Pharma authorized $1M buyback; OPAL scheduled Mar 16 earnings release.

News Intelligence

These disclosures affect your wallet. If you own shares in these companies, pay attention. La Rosa's salary cuts could mean cost-saving measures are in place. FibroBiologics' Nasdaq extension signals a struggle to stay listed. Silo Pharma's buyback could boost share value. Check your portfolio.

Media Bias

Articles Published:: 17
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 17

Who Benefited

Institutional investors and companies raising capital benefited through improved liquidity and resources to execute strategic projects, while issuers gained runway to pursue growth, restructure assets, and maintain exchange listings.

Who Impacted

Shareholders of underperforming subsidiaries, vendors, and employees subject to restructurings or cost reductions experienced near-term financial strain and increased operational uncertainty.

Media Bias

Articles Published:: 17
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 17
Distribution:: Left 0%, Center 100%, Right 0%

Who Benefited

Who Impacted

Shareholders of underperforming subsidiaries, vendors, and employees subject to restructurings or cost reductions experienced near-term financial strain and increased operational uncertainty.